Unique ID issued by UMIN | UMIN000032797 |
---|---|
Receipt number | R000037415 |
Scientific Title | Evaluation of the efficacy of ZEO STENT TM plus with a 14mm diameter for the distal biliary obstruction by pancreatic cancer. |
Date of disclosure of the study information | 2018/07/01 |
Last modified on | 2023/12/05 06:22:05 |
Evaluation of the efficacy of ZEO STENT TM plus with a 14mm diameter for the distal biliary obstruction by pancreatic cancer.
Evaluation of ZEO STENT TM plus.
Evaluation of the efficacy of ZEO STENT TM plus with a 14mm diameter for the distal biliary obstruction by pancreatic cancer.
Evaluation of ZEO STENT TM plus.
Japan |
Distal biliary obstruction by pancreatic cancer.
Hepato-biliary-pancreatic medicine |
Malignancy
NO
We evaluate the patency and the safety of ZEO STENT TM plus, a metal stent with a 14mm diameter, for distal biliary obstruction by pancreatic cancer. There is no previous report about the stent, and this study is aimed to clarify the efficacy of the stent.
Safety,Efficacy
Rate of recurrent biliary obstruction
Stent patency duration
Stent patency duration and the rate of stent function estimated by the Kaplan-Meier method
Median overall survival
Rate of complication
Adverse events in the therapeutic period and post therapeutic period
Complications related ERCP
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1) Distal biliary obstruction by pancreatic cancer
2) Expected survive more than 2 months
3) Age: >= 20 years at the time of acquiring consent
4) Written informed consent
5) ECOG Performance Status of 0-1
1)Massive ascites.
2)Uncontrolled other organ diseases
3)Biliary obstruction at the hilar part.
4)Unachievable ERCP due to post-abdominal surgery state including gastrectomy.
5)Unachievable ERCP due to difficult cannulation.
6)Distal duodenal obstruction. (Post-treatment state by stent placement excluded.)
7) Inappropriate patients for study.
30
1st name | Jun |
Middle name | |
Last name | Nakahodo |
Cancer and Infection Disease Center Komagome Hospital
Department of Gastroenterology
113-8677
3-18-22, Honkomagome Bunkyo-ku, Tokyo 113-8677 JAPAN
03-3823-2101
nakajun58@yahoo.co.jp
1st name | Jun |
Middle name | |
Last name | Nakahodo |
Cancer and Infection Disease Center Komagome Hospital
Department of Gastroenterology
113-8677
3-18-22, Honkomagome Bunkyo-ku, Tokyo 113-8677 JAPAN
03-3823-2101
nakajun58@yahoo.co.jp
Cancer and Infection Disease Center Komagome Hospital
None
Self funding
Cancer and Infection Disease Center Komagome Hospital
3-18-22, Honkomagome Bunkyo-ku, Tokyo 113-8677 JAPAN
03-3823-2101
rinri@cick.jp
NO
がん・感染症センター都立駒込病院(東京都)
2018 | Year | 07 | Month | 01 | Day |
Unpublished
Preinitiation
2018 | Year | 04 | Month | 17 | Day |
2018 | Year | 07 | Month | 01 | Day |
2020 | Year | 04 | Month | 01 | Day |
2020 | Year | 04 | Month | 01 | Day |
2020 | Year | 04 | Month | 01 | Day |
2020 | Year | 04 | Month | 01 | Day |
An uncovered and a covered metal stent were developed for relieving jaundice with a long-term patency. However, stent occlusion due to tumor ingrowth and stent migration were frequently experienced in an uncovered and a covered metal stent, respectively. Being uncovered and a large diameter of a stent could contribute to preventing recurrent biliary obstruction due to tumor ingrowth or migration.
2018 | Year | 05 | Month | 31 | Day |
2023 | Year | 12 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037415